Advances in chemoprevention of breast cancer / 肿瘤
Tumor
;
(12): 617-622, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-848375
ABSTRACT
Breast cancer is one of the most common malignant tumors in women, which seriously threatens the health of women. Estrogen promotes the development of breast cancer by binding to estrogen receptor and triggering a signaling cascade. The aromatase inhibitor (AI) and the selective estrogen receptor modulators (SERMs) prevent the effect of estrogenon promoting breast cancer through different mechanisms. Relevant studies have shown that SERMs and AI can effectively reduce the recurrence and metastasis of breast cancer, which suggests that they may effectively prevent the occurrence of breast cancer. The latest research progress in the randomized clinical trials of chemoprevention agents such as SERMs and AI are reviewed in this paper.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Chino
Revista:
Tumor
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS